Two Sigma Securities’s ENDRA Life Sciences NDRA Stock Holding History

Two Sigma Securities’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-549	Closed	-$3.86K	–	2675
2024 Q3	$3.86K	Buy	+549	New	+$42.5K	﹤0.01%	2682
2024 Q2	–	Sell	-27	Closed	-$27.8K	–	3425
2024 Q1	$27.8K	Buy	+27	New	+$53K	﹤0.01%	2639
2023 Q3	–	Sell	-6	Closed	-$15.9K	–	3293
2023 Q2	$15.9K	Buy	+6	New	+$16.9K	﹤0.01%	2534
2022 Q3	–	Sell	-2	Closed	-$18K	–	2920
2022 Q2	$18K	Hold	2	–	–	﹤0.01%	1973
2022 Q1	$22K	Buy	+2	New	+$35.9K	﹤0.01%	1964
2019 Q2	–	Hold	0	–	-$22K	–	2306
2019 Q1	–	Hold	0	–	–	–	1667

Other funds holding NDRA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Two Sigma Securities's NDRA Position: Q4 2024 in Review

Two Sigma Securities sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 549 shares — an estimated $3.86K sold.

Two Sigma Securities first reported a position in NDRA in Q1 2022 and held it in 5 quarters. The position peaked at $27.8K in Q1 2024. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

Two Sigma Securities reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
Two Sigma Securities sold 549 ENDRA Life Sciences shares in Q4 2024, an estimated $3.86K.
Two Sigma Securities first reported a position in ENDRA Life Sciences in Q1 2022 and held it in 5 quarters.
Two Sigma Securities's ENDRA Life Sciences position peaked at $27.8K in Q1 2024.
4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.